Moneta Porcupine Mines | Canada's Most Prolific Gold Mining Camp -
•Apr 23, 2020
In this video the CEO of Moneta Porcupine Mines, Gary O'Connor,
talks about the company's gold exploration in the Timmins Gold Camp.
Moneta Porcupine Mines is a gold exploration company that holds
a 100% interest in 6 core gold projects and
a 50% JV with Kirkland Lake Gold strategically located on or
along the Destor Porcupine Fault Zone corridor ("Destor").
Destor is one of the key mineralized structures in
the Abitibi Greenstone belt in Ontario and has excellent
infrastructure including access roads, water, electricity
and mills.
All of the Moneta's properties are in the Timmins Gold Camp.
They're exploring for gold deposits along
the Destor Porcupine, Canada's most prolific gold mining camp.
https://www.youtube.com/watch?v=dCvqvuGT47c&t=11s
In Conversation: Gary O'Connor @Moneta Porcupine -
A solid Ontario position and backing from strategic investors.
What will 2020 bring for Moneta Porcupine?
https://www.youtube.com/watch?v=Z7BCFrPq_Wg
New May 2020 corporate presentation out by Moneta Porcupine Mines Inc
(TSX:ME) -
Check it out. Some new items I noticed:
There are 2 analysts covering ME:
PAradigm and Haywood, Sprott has increased holdings in ME.
There is also their 10 year plan.
Check it out:
https://www.monetaporcupine.com/corporate-presentation/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155397104
In GOD We Trust -
![](http://www.kitco.com/images/live/gold.gif?0.8344882022363285)
https://www.kitco.com/images/live/silver.gif?0.8344882022363285
![](http://www.kitco.com/images/live/silver.gif?0.8344882022363285)
![](http://www.kitconet.com/images/live/au0001wb.gif)
![](http://www.kitconet.com/images/live/ag0001wb.gif)
http://www.kitconet.com/images/live/au0001wb.gif
Gold & Silver is the only REAL Legal Tender -
by The Founding Fathers for your -
Rights, Liberty and Freedom -
http://www.biblebelievers.org.au/monie.htm
God Bless America
Ps.
opinion appreciated
TIA
Recent ME News
- 23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel • GlobeNewswire Inc. • 06/28/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:17:11 PM
- 23andMe Launches New Genetic Report on Bipolar Disorder • GlobeNewswire Inc. • 06/05/2024 11:00:00 AM
- 23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black Community • GlobeNewswire Inc. • 06/04/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 12:06:02 PM
- 23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting • GlobeNewswire Inc. • 06/03/2024 12:00:00 PM
- Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and history • GlobeNewswire Inc. • 05/29/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:06:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2024 09:15:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:07:02 PM
- 23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results • GlobeNewswire Inc. • 05/23/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 08:07:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 08:06:05 PM
- Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals • GlobeNewswire Inc. • 05/14/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 08:06:05 PM
- 23andMe to Report Q4 and Full Year FY2024 Financial Results • GlobeNewswire Inc. • 05/09/2024 08:50:07 PM
- Potter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach Case • Business Wire • 04/30/2024 03:00:00 PM
- 23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 04/24/2024 08:05:00 PM
- 23andMe announces CEO’s intention to pursue a potential take-private • GlobeNewswire Inc. • 04/18/2024 12:00:00 PM
- 23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 • GlobeNewswire Inc. • 04/05/2024 08:05:00 PM
- 23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6 • GlobeNewswire Inc. • 03/20/2024 11:30:00 AM
- 23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago • GlobeNewswire Inc. • 03/19/2024 12:00:00 PM
- 23andMe Launches New Genetic Reports on Common Forms of Cancer • GlobeNewswire Inc. • 03/06/2024 12:30:00 PM
- 23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:36:48 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM